CHLORAMBUCIL News

CHLORAMBUCIL currently has 8 news articles, with 17 predicted indications.

This page combines the AI-predicted indications for CHLORAMBUCIL with the latest health news. Indications highlighted in orange have recent news coverage.

Drug Information

Evidence level: L5
Predicted indications (17):
- follicular lymphoma (99.0%)
- Hodgkin's paragranuloma (99.0%)
- acute lymphoblastic/lymphocytic leukemia (99.0%)
- obsolete Hodgkin's granuloma (99.0%)
- neoplasm of mature B-cells (99.0%)
- classic Hodgkin lymphoma (99.0%)
- classic Hodgkin lymphoma, lymphocyte-rich type (99.0%)
- Richter syndrome (99.0%)
- Hodgkins lymphoma (99.0%)
- chronic lymphocytic leukemia/small lymphocytic lymphoma with immunoglobulin heavy chain variable-region gene somatic hypermutation (99.7%)
- pregerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma (99.7%)
- ALK-positive large B-cell lymphoma (99.6%)
- primary pulmonary lymphoma (99.4%)
- well-differentiated fetal adenocarcinoma of the lung (99.4%)
- pulmonary blastoma (99.4%)
- acute lymphoblastic leukemia (disease) (99.2%)
- small cell lung carcinoma (99.2%)